Wanjia Group Holdings (HKSE:00401) Growth Rank : 0 (As of May. 31, 2024)

View and export this data going back to 2013. Start your Free Trial

What is Wanjia Group Holdings Growth Rank?

Wanjia Group Holdings has the Growth Rank of 0.

GuruFocus Growth Rank measures the growth of a company in terms of its revenue and profitability. Historically, the companies with the highest growth ranks performed the best over the long term. It is calculated using the following criteria:

1. 5-year revenue growth rate, the higher, the better.
2. 3-year revenue growth rate, the higher, the better.
3. 5-year EBITDA growth rate, the higher, the better.
4. The predictability of 5-year revenue. The most consistent it is, the higher the rank.

GuruFocus found that the Growth Rank is the second of the two most-sensitive parameters among the five parameters checked. Please click GF Score to see more details on GF Score's 5 Key Aspects of Analysis.

Please note that we are using the five-year EBITDA growth rate as a parameter, so the company needs to have had positive growth over that time. The reason we use EBITDA instead of earnings per share is that with EBITDA, we can rank a lot more companies since a company may have positive EBITDA but negative EPS. Since we are looking at the growth here, EBITDA gives us a pretty clear picture about the growth in the company's business operations.

Wanjia Group Holdings Growth Rank Related Terms

Thank you for viewing the detailed overview of Wanjia Group Holdings's Growth Rank provided by GuruFocus.com. Please click on the following links to see related term pages.

Wanjia Group Holdings (HKSE:00401) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Distribution » Wanjia Group Holdings Ltd (HKSE:00401) » Definitions » Growth Rank

Comparable Companies

Traded in Other Exchanges

N/A

Address

25 Canton Road, Harbour City, Suite 1801, 18th Floor, Tower 1, The Gateway, Kowloon, Hong Kong, HKG

Website

https://www.wanjia-gp.com

Wanjia Group Holdings Ltd is an investment holding company. Along with its subsidiaries, the company operates in principal activities of Pharmaceutical wholesale and distribution business, and Hemodialysis treatment and consultancy service business. The company generates key revenue from the Hemodialysis treatment and consultancy service business.

Executives

Wang Jia Jun	2101 Beneficial owner
Expert Wealth Investments Limited	2201 Interest of corporation controlled by you
Grand Harbour Finance Limited	2106 Person having a security interest in shares
Yung Ka Lai	2101 Beneficial owner
Ng Kwok Fai	2201 Interest of corporation controlled by you
Wei Yang Tou Zi Fa Zhan You Xian Gong Si	2101 Beneficial owner
Li Wei	2202 Interest of your spouse
Liu Chang	2201 Interest of corporation controlled by you
Liu Yonghao	2201 Interest of corporation controlled by you
Nan Fang Xi Wang Shi Ye You Xian Gong Si	2201 Interest of corporation controlled by you
Xin Xi Wang Ji Tuan You Xian Gong Si	2201 Interest of corporation controlled by you
Xi Zang Heng Ye Feng Shi Ye You Xian Gong Si	2201 Interest of corporation controlled by you

Wanjia Group Holdings (HKSE:00401) Headlines

No Headlines